Interim data from study supports Favipiravir's safety, effectiveness: GlenmarkThe study, commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.
09 Jun, 2021, 12.33 AM IST
Gambhir's foundation guilty of un-authorised stocking, distributing COVID medicines, Delhi HC toldThe drug controller submitted that action will be taken without delay against the foundation, drug dealers as also in other such cases whic...
03 Jun, 2021, 01.52 PM IST
HC pulls up drug controller for not properly examining how Gambhir got huge quantities of FabifluThe high court said its confidence in the drug controller has shaken and rejected its status report filed in connection with its inquiry in...
31 May, 2021, 04.41 PM IST
COVID crisis: Goa Airport plans to organize vaccination camp for AAI employees, airlines, othersGoa Airport is making efforts to organize COVID vaccination camp for the employees of AAI and their dependent family members, airlines, age...
07 May, 2021, 01.18 PM IST
Online pharmacy firms see massive order surge in second waveHigh caseloads in cities coupled with regional lockdowns, especially in large metros, has pushed consumers to order online than visit offli...
05 May, 2021, 01.35 AM IST
Crisis over shortage of Remdesivir, Fabiflu to end by next fortnight"An unprecedented surge in demand of some crucial medicines, used in treating Covid patients, has created a mess. Now companies like Cipla ...
01 May, 2021, 12.32 PM IST
Gambhir says his foundation would distribute Fabiflu, oxygen cylinders across Delhi"Delhi is my home and I will keep serving the people till my last breath. With many requests for beds, oxygen and medicines, we are helping...
25 Apr, 2021, 01.28 PM IST
Book those black-marketing medicines like Remdesivir under NSA: Yogi AdityanathChairing a review meeting with his core team of 11 top officials, Adityanath reiterated that there was no plan to impose a lockdown in the ...
21 Apr, 2021, 03.22 PM IST
Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
23 Nov, 2020, 02.49 PM IST
Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...
06 Aug, 2020, 04.01 PM IST
Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
21 Jul, 2020, 12.20 PM IST
Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug, overpricing complaintsThe drug regulator also pulled up Glenmark over the pricing of the drug, after receiving a complaint from a member of Parliament.
20 Jul, 2020, 11.16 AM IST
DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFluDrug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.
19 Jul, 2020, 06.17 PM IST
Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...
13 Jul, 2020, 12.38 PM IST
Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
23 Jun, 2020, 09.36 PM IST
Glenmark Pharma drops 5% after HSBC Pooled Investment Fund sold stakeAfter rallying 27 per cent in the previous session, the scrip traded 5.24 per cent lower at Rs 492.
23 Jun, 2020, 01.14 PM IST
Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
22 Jun, 2020, 03.50 PM IST